Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:26 PM
Ignite Modification Date: 2025-12-24 @ 6:26 PM
NCT ID: NCT01638468
Eligibility Criteria: Inclusion Criteria: 1. Symptomatic pulmonary embolism patients \>18 years 2. Availability of a baseline contrast-enhanced chest computed tomogram or conventional pulmonary angiogram with evidence of pulmonary embolus in at least one main or lobar pulmonary artery ≥ 6mm in diameter 3. Availability of a baseline transthoracic echocardiogram with sufficient image quality permitting the measurement of right ventricular (RV) and left ventricular (LV) dimensions in the apical or subcostal four-chamber view 4. Echocardiographic evidence of right ventricular dilatation with a subannular RV/LV ratio ≥ 0.9 from the apical or subcostal four-chamber view 5. Appropriate informed consent was obtained from the patient or legal representative Exclusion Criteria: 1. Patient has underwent Cardiopulmonary Resuscitation (CPR) in the last 48 hours 2. Patient is participating in any other clinical study 3. Pregnancy, lactation or parturition within the previous 30 days (positive pregnancy test, women of childbearing age must be tested or use a medically accepted method of birth control) 4. Inability to comply with study Follow-up assessments (e.g. due to geographic) 5. Previous enrollment in this study
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT01638468
Study Brief:
Protocol Section: NCT01638468